Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

rx:cc

POPULAR ARTICLES

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

pharmaceutical investing

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

pharmaceutical investing

FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years

BioSyent Announces Grant of Restricted Share Units

pharmaceutical investing

BioSyent Announces Grant of Restricted Share Units

LATEST ARTICLES

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

pharmaceutical investing

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

pharmaceutical investing

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

pharmaceutical investing

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

BioSyent to Acquire Oral Science Inc.

pharmaceutical investing

BioSyent to Acquire Oral Science Inc.

BioSyent Declares First Quarter 2026 Dividend

pharmaceutical investing

BioSyent Declares First Quarter 2026 Dividend

BioSyent Announces Renewal of Normal Course Issuer Bid

pharmaceutical investing

BioSyent Announces Renewal of Normal Course Issuer Bid

BioSyent Releases Financial Results for Q3 and YTD 2025

pharmaceutical investing

BioSyent Releases Financial Results for Q3 and YTD 2025

BioSyent Declares Fourth Quarter 2025 Dividend

pharmaceutical investing

BioSyent Declares Fourth Quarter 2025 Dividend

BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025

pharmaceutical investing

BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025

BioSyent Releases Financial Results for Q2 and H1 2025

pharmaceutical investing

BioSyent Releases Financial Results for Q2 and H1 2025

BioSyent Declares Third Quarter 2025 Dividend

pharmaceutical investing

BioSyent Declares Third Quarter 2025 Dividend

BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025

pharmaceutical investing

BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025

Latest News

CHARBONE Announces Closing of $10M Convertible Loan Including $3M Initial Tranche

CHARBONE annonce la cloture du pret convertible de 10 M$ incluant 3 M$ en tranche initiale

Allied Critical Metals Announces Intent to List on the TSX Venture Exchange

Surface Metals Inc. Expands Land Holdings in Advance of Drilling Campaign at Cimarron Gold Project, Nevada

QIMC Intersects Major Fault Breccia System in DDH-26-03 at West Advocate and Reports Elevated Hydrogen 2.5 km from the Initial Discovery

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Excalibur Metals

Excalibur Metals (EXCL:CC)

EXCL:CC

Blue Jay Gold

Blue Jay Gold (None)

Heliostar Metals

Heliostar Metals (HSTR:CC)

HSTR:CC

Silver Dollar Resources

Silver Dollar Resources (SLV:CC)

SLV:CC

Metals.io

Metals.io ()

Lexaria Bioscience

Lexaria Bioscience (LEXX)

LEXX

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES